Perspective Therapeutics, Inc. (CATX) Stock Grade

About Perspective Therapeutics, Inc.'s fundamentals

Perspective Therapeutics is a medical device company with a market capitalization of $203.0 million that reported a net loss in its latest annual statement, resulting in a 0.0% net margin. The company experienced a sharp -100.0% year-over-year revenue decline, indicating it either ceased operations or underwent a significant business restructuring. With no dividend yield and unable to calculate profitability-based metrics like P/E ratio and return on equity, the company is currently in a non-profitable, pre-revenue or transition phase.